Your browser doesn't support javascript.
loading
Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC.
Yu, Yishan; Fu, Pingfu; Jin, Jian-Yue; Gao, Siming; Wang, Weili; Machtay, Mitchell; Wang, Linlin; Kong, Feng-Ming Spring; Yu, Jinming.
Afiliación
  • Yu Y; School of Medicine, Shandong University, Jinan, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Fu P; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, USA.
  • Jin JY; Department of Radiation Oncology, Seidman Cancer Center, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, USA.
  • Gao S; School of Medicine, Shandong University, Jinan, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Wang W; Department of Radiation Oncology, Seidman Cancer Center, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, USA.
  • Machtay M; Department of Radiation Oncology, Seidman Cancer Center, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, USA.
  • Wang L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Kong FS; Department of Radiation Oncology, Seidman Cancer Center, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, USA; Department of Clinical Oncology, Hong Kong University Li Ka Shing Medical School, Hong Kong University Shenzhen Hospital, Hong K
  • Yu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. Electronic address: sdyujinming@126.com.
Radiother Oncol ; 162: 26-33, 2021 09.
Article en En | MEDLINE | ID: mdl-34139210
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Irlanda